SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Coral Laboratories - Quaterly Results

14 Feb 2026 Evaluate
The sales slipped to Rs. 215.64 millions for the December 2025 quarter as against Rs. 229.86 millions during the year-ago period.Net Profit of the company move down -54.83% to Rs. 27.75  millions from Rs. 61.44 millions  in the same quarter last year.Operating profit for the quarter ended December 2025 decreased to 43.83 millions as compared to 88.35 millions of corresponding quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 215.64 229.86 -6.19 594.20 868.71 -31.60 1150.05 836.60 37.47
Other Income 24.93 25.23 -1.19 72.50 66.27 9.40 91.09 66.32 37.35
PBIDT 43.83 88.35 -50.39 162.62 301.82 -46.12 353.48 228.71 54.55
Interest 0.01 0.19 -94.74 1.62 0.58 179.31 0.98 0.00 0.00
PBDT 43.82 88.16 -50.29 164.22 301.24 -45.49 344.80 227.07 51.85
Depreciation 6.87 5.02 36.85 15.92 15.05 5.78 20.11 19.76 1.77
PBT 36.95 83.14 -55.56 148.30 286.19 -48.18 324.69 207.31 56.62
TAX 9.20 21.70 -57.60 36.70 72.90 -49.66 83.15 49.43 68.22
Deferred Tax 0.20 0.20 0.00 0.30 0.60 -50.00 -0.15 0.34 -144.12
PAT 27.75 61.44 -54.83 111.60 213.29 -47.68 241.54 157.88 52.99
Equity 35.73 35.73 0.00 35.73 35.73 0.00 35.73 35.73 0.00
PBIDTM(%) 20.33 38.44 -47.12 27.37 34.74 -21.23 30.74 27.34 12.43

Coral Laboratories Share Price

419.55 -2.35 (-0.56%)
16-Apr-2026 12:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1674.70
Dr. Reddys Lab 1223.00
Cipla 1231.75
Zydus Lifesciences 935.75
Lupin 2301.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×